MC Pharma SRL
MC Pharma reported total assets of 28,699 € at the end of the 2025 financial year (annual accounts filed with the NBB on 15 Jul 2026).
The score of MC Pharma shows with a free account.
See the score- Summary? / 5
- Balance sheet strength
- Liquidity
- Repayment capacity
- Profitability
- Trajectory
- Compliance and register
- Position in its sectorvs peers
- Supplier creditat 30 d
- Borrowing capacityborrowable
- Valuationcentral
Visible once signed in: create your account, the 14-day Pro trial is free.
Key figures 2025
Accounts of the company itself (not consolidated).
Deterministic calculation on the filed accounts, no AI. Dispute the score or report an error
MC Pharma's annual accounts
| 2025 | |
|---|---|
| Net result | 21,578 € |
| Equity | 25,578 € |
| Cash | 13,121 € |
| EBITDA | 29,923 € |
| Total assets | 28,699 € |
Filed annual accounts
- Year ended 31 Dec 2025filed on 15 Jul 2026
MC Pharma's financial analysis
- Solvency89.1%sector median: 38.7%
- Current ratio
- Net margin
- ROE
- Financial debt / EBITDA
- Interest coverage
- Days sales outstanding (DSO)
Management and control of MC Pharma
MC Pharma's publications in the Belgian Gazette
Company number, VAT number and registered office
- Company number (CBE)
- 1022.680.304
- VAT number
- BE1022680304
- Peppol
- Registered · 0208:1022680304 · as of 10 Nov 2026
- Legal form
- SRL
- Incorporated
- 24 Apr 2025
- Registered office
- 6500 Beaumont
- Latest accounts
- 2025 · filed on 15 Jul 2026
- Activity
- Manufacture of basic pharmaceutical products (NACE 21100)
MC Pharma (SRL) has been based in Beaumont since 2025, active in: manufacture of basic pharmaceutical products. For 2025, it reports a net profit of 21,578 € and equity of 25,578 €; its revenue is not published. Its solvency stands at 89.1%, above the median of its sector (38.7%).
Companies similar to MC Pharma
Companies in the same business, of comparable size and area, outside its group.
- Biomdrin Manufacture of pharmaceutical preparations Schilde · balance sheet 38,268 €
- Inchinn Therapeutics Manufacture of basic pharmaceutical products Charleroi · balance sheet 51,394 €
- Estrella Clinical Research Manufacture of basic pharmaceutical products Herentals · balance sheet 41,482 €
- Chris Pharma Works Manufacture of basic pharmaceutical products Profondeville · balance sheet 24,086 €
- Pranarom MED Manufacture of basic pharmaceutical products Ath · balance sheet 24,820 €
- Premium Pharma Retail Manufacture of basic pharmaceutical products Molenbeek-Saint-Jean · balance sheet 34,216 €
- Apcor R&M Manufacture of basic pharmaceutical products Ghent · balance sheet 5,677 €
- Raya Therapeutic Manufacture of basic pharmaceutical products Leuven · balance sheet 5,330 €
Frequently asked questions about MC Pharma
What is the revenue of MC Pharma?
MC Pharma files its accounts in a format where revenue is optional: it is not published for 2025.
What is the VAT number of MC Pharma?
In Belgium, the VAT number is the company number prefixed with BE: BE1022680304 for MC Pharma, if the company is VAT-registered. Its company number (CBE) is 1022.680.304.
Where is the registered office of MC Pharma?
According to the CBE register, the registered office of MC Pharma is in 6500 Beaumont.
What is the equity of MC Pharma?
At the close of the 2025 financial year, the equity of MC Pharma amounts to 25,578 €, a solvency of 89.1% of total assets.
Who manages MC Pharma?
The register lists 1 active mandates at MC Pharma. Names and roles are in the full file, with the deeds published in the Belgian Gazette.
The full file of MC Pharma
Directors and mandates, ownership network, Gazette deeds, ten years of accounts and ratios, Excel export, and Idonis's analysis in one question.
Open the full file →